This year, World CDx Boston brings you perspectives and exclusive case studies from more CDx stakeholders than ever before. With dedicated conference streams addressing the biggest commercial, clinical and regulatory topics, plus over 20 hours of face to face networking time with your CDx peers and future partners. Develop your own comprehensive strategy for successfully developing personalized medicines by providing solutions to some of the sector’s biggest challenges.
The key questions we will be answering are:
How do we now define the ‘Gold Standard’ of the development, approval and commercialization of companion diagnostics? Where is the Personalized Medicine field headed and what does this mean for CDx stakeholders large and small?
What does the industry still need in terms of regulatory clarity and reimbursement support? How do we work together to promote better communication and return on investment?
What are the most exciting technology developments in the field of Personalized Medicine? Is sequencing really the future? How do we translate these leaps in technological innovation into real-world results?
How do you turn a drug and a diagnostic test into a fruitful commercial partnership? Learn how the world’s leading companies are selecting their own business models to speed market access and share the risks and rewards.
Where can industry improve its communication with and understanding of other CDx stakeholders? Clinicians, patient groups and payers are all represented this year, how are they really benefiting from CDx development?